Bret Hankey serves as Executive at Bone Biologics Corp, where they oversee executive responsibilities. Since joining the company, Bret Hankey has executed 7 insider transactions totaling $195.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 2, 2020 involved purchasing 195,000 shares valued at $195.0K.
Bret Hankey currently holds 28,122,518 shares of Bone Biologics Corp (BBLG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bret Hankey has been a net buyer of BBLG stock. They have purchased $195.0K and sold $0 worth of shares.
Bret Hankey's most recent insider trade was on Jan 2, 2020, when they purchased 195,000 shares at $1.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 15, 2019 | BBLG | $0 | Purchase | 85,106 | $N/A | Discretionary |
| Jun 20, 2019 | BBLG | $0 | Purchase | 1,063,830 | $N/A | Discretionary |
| May 7, 2019 | BBLG | $0 | Purchase | 1,063,830 | $N/A | Discretionary |
| Mar 25, 2019 | BBLG | $0 | Purchase | 1,489,362 | $N/A | Discretionary |
| Dec 17, 2018 | BBLG | $0 | Purchase | 18,009,696 | $N/A | Discretionary |